Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients

Itzhaki, O; Jacoby, E; Nissani, A; Levi, M; Nagler, A; Kubi, A; Brezinger, K; Brayer, H; Zeltzer, LA; Rozenbaum, M; Vernitsky, H; Markel, G; Toren, A; Avigdor, A; Schachter, J; Besser, MJ

Besser, MJ (corresponding author), Sheba Med Ctr, Ella Lemelbaum Inst Immuno Oncol, Tel Hashomer, Israel.; Besser, MJ (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, Tel Aviv, Israel.; Besser, MJ (corresponding author), Sheba Med Ctr, Wohl Inst Translat Med, Tel Hashomer, Israel.

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020; 8 (1):

Abstract

Background CD19 chimeric antigen receptor T (CAR-T) cells demonstrate remarkable remission rates in pediatric and adult patients with refractory or re......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索